Mochida links with Mitsubishi Tanabe for escitalopram
08 January 2010
Ian Haydock
Please Login to read the full article.
08 January 2010
Ian Haydock
ian.haydock@informa.com
Mitsubishi Tanabe Pharma (MTP) has entered into an agreement for the co-marketing of the selective serotonin reuptake inhibitor escitalopram in Japan.
It will sell the product together with local developer
Mochida, which has licensed Japanese rights from originator Lundbeck and is currently...
Please Login to read the full article.
RELATED CONTENT
EVENTS
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
26 March 2012
Copenhagen, Denmark
JOB OF THE WEEK
Promote your vacancy here
